Mehta on the Phase 3 METIS Trial of TTFields for Brain Metastases in NSCLC

1 year ago 78

Minesh Mehta, MD, discusses positive findings from the phase 3 METIS trial investigating TTFields therapy for brain metastases in NSCLC.

1. Homepage
2. Lung Cancer
3. Mehta on the Phase 3 METIS Trial of TTFields for Brain Metastases in NSCLC